CYTK
Cytokinetics
·
$80.18
Leader · accounting warning — verify before buying领先 · 财务质量警示 — 买入前先核实
Terminal终端 ↗
Cytokinetics · Health Care
CYTK
$80.18
Cytokinetics, Incorporated, is a biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function.Cytokinetics,Incorporated是一家生物制药公司，总部位于加利福尼亚州南旧金山，专注于开发肌肉激活剂和肌肉抑制剂，作为肌肉功能受损或衰退疾病的潜在治疗方案。
Speculative / unprofitable投机／未盈利
Mid cap中盘
$10B
Engine stance引擎立场2026-07-20
Leader · accounting warning — verify before buying领先 · 财务质量警示 — 买入前先核实
The bottoming setup is not yet confirmed (price still below the 10-day average) and the 3-day/weekly momentum is rolling筑底形态尚未确认（价格仍位于 10 日均线下方），且3 日/周线动量已开始掉头向下——动量在形态完成前已开始衰竭。等待价格收复 10 日均线且动量趋于稳定后再考虑建仓。
Key Statistics关键统计
Price价格
$80.18
8.1% below 52-week high低于52周高点 8.1%
Market Cap市值
$10B
Normal volume正常成交量
Beta贝塔
0.74
Moves about 0.7x the market波动幅度约为市场的 0.7 倍
RSI (14)RSI（14）
49
Neutral zone中性区域
Next Earnings下次财报
2026-08-06 (18d)
Volatility Rank波动率分位
5th pctile
hist. vol. percentile历史波动率分位数
Short Interest空头兴趣
14.3% of float
Performance价格表现
| Period周期 | CYTK | S&P 500 | vs Index对比指数 |
|---|---|---|---|
| 1 Week近1周 | -5.5% | -1.5% | Lagged the index by 4.0 points落后指数 4.0 个百分点 |
| 1 Month近1月 | +2.7% | +0.6% | Beat the index by 2.1 points跑赢指数 2.1 个百分点 |
| 3 Months近3月 | +20.2% | +4.7% | Beat the index by 15.5 points跑赢指数 15.5 个百分点 |
| 6 Months近6月 | +28.1% | +7.8% | Beat the index by 20.3 points跑赢指数 20.3 个百分点 |
| Year to date年初至今 | +29.9% | +9.1% | Beat the index by 20.8 points跑赢指数 20.8 个百分点 |
| 1 Year近1年 | +106.2% | +19.4% | Beat the index by 86.8 points跑赢指数 86.8 个百分点 |
| 3 Years近3年 | +141.6% | +69.4% | Beat the index by 72.2 points跑赢指数 72.2 个百分点 |
Technicals技术面
RSI (14)RSI（14）
49
Neutral zone中性区域
vs 50-day相对50日均线
+3.1% vs 50-day avg
vs 200-day相对200日均线
+19.9% vs 200-day avg
Volatility rank波动率分位
5th percentile 分位
Engine reference levels — not advice引擎参考水平 — 非投资建议
Buy zone买入区间
$78.29
Don't chase above不追高于
$80.18
Stop止损
$69.27
Extended — wait for a pullback过度拉伸 — 等待回撤
Earnings财务业绩
18
days until next report天后公布财报
2026-08-06
Estimates being cut预期下调
Earnings call transcripts — coming soon财报电话会议记录 — 即将上线
Valuation估值
| Multiple指标 | CYTK | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/S市销率 | 111.97x | 3.02 | 1% |
| Earnings yield盈利收益率 | -7.96% | 2.72 | 10% |
| FCF yield自由现金流收益率 | -5.43% | 3.94 | 6% |
Analyst price targets — coming soon分析师目标价 — 即将上线
Financials财务数据
Revenue营业收入
5yr CAGR5年复合增速: 9.5%
Earnings Per Share每股收益
Free Cash Flow自由现金流
Margins利润率
119.0%Return on Equity股本回报率
-55.1%Return on Assets资产回报率
Leverage杠杆
| Current ratio流动比率 | 4.53 |
Capital Allocation资本配置
| Stock-based comp股权薪酬 | $112.3M |
| Share count change (1y)股数变化（1年） | +4.0% |
Piotroski皮奥特罗斯基 2/8
Altman Z阿尔特曼Z: distress (-1.3)
Warning警示
Snapshot Gauges综合指标
Valuation vs Sector估值相对行业
Expensive vs sector相对行业偏贵
Cheaper than 4% of its sector on blended multiples综合估值倍数低于行业内 4% 的公司
Beta市场敏感度
0.74×
0.21×3×
Moves about 0.7× the market波动幅度约为市场的 0.7 倍
Financial Health财务健康
2/8
Altman阿尔特曼: distress
Weak financial health财务健康状况偏弱
Dividend分红
—
Does not pay a dividend不派发股息
Why Is It Moving为何波动
Macro宏观
Long-duration name into a restrictive, rising-real-rate regime → rate headwind.长久期标的进入偏紧、实际利率上行的环境→利率逆风。
Positioning持仓
Short interest changed +19.0%空头仓位变动 +19.0%
Technical技术面
CYTK daily MACD crossed downCYTK 日线MACD下穿
Ownership & Smart Money持仓与聪明钱
Insider activity内部人员活动: -$19.7M net (0 buyers, 9 sellers)-$19.7M 净值（0 买家，9 卖家）
Concentrated ownership集中持仓
| Fund基金 | Grade评级 | Activity动作 | % of portfolio组合占比 | As of截至 |
|---|---|---|---|---|
| RTW Investments | B | Holding持有 | 1.8% | 2026-03-31 |
| Polen Capital Management | B | exitexit | 0.0% | 2026-03-31 |
Signal History信号历史
TURN SIGNALED
BOTTOMING
Jul 13, 2026
CYTK daily MACD crossed downCYTK 日线MACD下穿
The daily MACD histogram turned negative — fast and noisy, context rather than a standalone trigger. $82.24.日线MACD柱状图转负 — 快速且嘈杂，仅作背景。$82.24。
Jul 7, 2026
BOTTOMING → NEARING A HIGH筑底中 → 接近高点
TAKE PROFITS止盈
Jul 6, 2026
NEARING A HIGH → BOTTOMING接近高点 → 筑底中
BUY SETUP买入预备
Jul 2, 2026
UPTREND → NEARING A HIGH上涨趋势 → 接近高点
TAKE PROFITS止盈
Jul 2, 2026
CYTK RSI reached overboughtCYTK RSI进入超买
RSI(14) crossed above 70 — stretched to the upside; context, not a timing trigger alone. $86.49.RSI(14)上穿70 — 上行过度；仅作背景，单独不构成择时。$86.49。
Jun 30, 2026
NEARING A HIGH → UPTREND接近高点 → 上涨趋势
HOLD持有
Jun 29, 2026
BOTTOMING → NEARING A HIGH筑底中 → 接近高点
TAKE PROFITS止盈
Jun 29, 2026
CYTK RSI reached overboughtCYTK RSI进入超买
RSI(14) crossed above 70 — stretched to the upside; context, not a timing trigger alone. $87.26.RSI(14)上穿70 — 上行过度；仅作背景，单独不构成择时。$87.26。
Jun 26, 2026
CYTK made a new 52-week highCYTK 创52周新高
Price reached a fresh 52-week high — a momentum / trend extreme the whole market watches. $82.19.价格创出52周新高 — 全市场关注的动量/趋势极值。$82.19。
Showing last 15 of显示最近15条，共 233 signals条信号
Factor Profile因子特征
Composite factor score综合因子得分: -0.05
Value价值
-1.9
Quality质量
+2.7
Investment资本投入
+0.4
Low volatility低波动
-1.4
Low market beta低市场敏感度
+0.1
Earnings quality盈利质量
+2.5
Short interest空头兴趣
-1.3
Company Profile公司档案
Cytokinetics, Incorporated, is a biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function.Cytokinetics,Incorporated是一家生物制药公司，总部位于加利福尼亚州南旧金山，专注于开发肌肉激活剂和肌肉抑制剂，作为肌肉功能受损或衰退疾病的潜在治疗方案。
Watch items — what could change the thesis关注项 — 可能改变论点的因素
- Capital intensity rising
Get the full picture获取完整视图
Nightly signals, options flow, and factor analysis across all S&P 500 names.每日更新的信号、期权资金流向和因子分析，覆盖所有标普500成分股。